scholarly journals The Long-Term Results of Left Internal Thoracic Artery Grafting in the Left Anterior Descending Artery with Either a Sternotomy or an Anterior Minithoracotomy

2007 ◽  
Vol 36 (5) ◽  
pp. 245-247
Author(s):  
Hidehiko Iwahashi ◽  
Tadashi Tashiro ◽  
Noritugu Morishige ◽  
Yoshio Hayashida ◽  
Nobuhisa Ito ◽  
...  
2009 ◽  
Vol 56 (S 01) ◽  
Author(s):  
P Risteski ◽  
A Rahman ◽  
A Rouhollahpour ◽  
S Martens ◽  
A Moritz ◽  
...  

2007 ◽  
Vol 83 (2) ◽  
pp. 496-501 ◽  
Author(s):  
Temucin Noyan Ogus ◽  
Murat Basaran ◽  
Ozer Selimoglu ◽  
Tekin Yildirim ◽  
Halide Ogus ◽  
...  

Author(s):  
Shinji Ogawa ◽  
Tomohiro Tsunekawa ◽  
Soh Hosoba ◽  
Yoshihiro Goto ◽  
Takayoshi Kato ◽  
...  

Abstract OBJECTIVES To compare different configurations of the bilateral internal thoracic arteries for the left coronary system and examine early and late outcomes, including mid-term graft patency. METHODS We reviewed 877 patients who underwent primary isolated coronary artery bypass grafting using in situ bilateral internal thoracic arteries [in situ right internal thoracic artery (RITA)-to-left anterior descending artery (LAD) grafting, n = 683; in situ left internal thoracic artery (LITA)-to-LAD grafting, n = 194]. We compared mid-term patency between the grafts. Propensity score matching was performed to investigate early and long-term outcomes. RESULTS The 2-year patency rate for RITA-to-LAD and LITA-to-LAD grafts were similar. Multivariate analysis revealed that RITA-to-non-LAD anastomosis (P = 0.029), postoperative length of stay (P = 0.003) and chronic obstructive pulmonary disease (P = 0.005) were associated with graft failure. After statistical adjustment, 176 propensity-matched pairs were available for comparison. RITA-to-LAD grafting enabled a more distal anastomosis. Kaplan–Meier analysis revealed that the incidences of death, repeat revascularization and myocardial infarction were significantly higher in the LITA-to-LAD group among both the unmatched and matched samples (P = 0.045 and 0.029, respectively). CONCLUSIONS The mid-term patency and outcomes of RITA-to-LAD grafting are good and reduces future cardiac event, in contrast to LITA-to-LAD grafting.


Circulation ◽  
2020 ◽  
Vol 142 (14) ◽  
pp. 1330-1338 ◽  
Author(s):  
Brian F. Buxton ◽  
Philip A. Hayward ◽  
Jai Raman ◽  
Simon C. Moten ◽  
Alexander Rosalion ◽  
...  

Background: An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). Methods: In RAPCO-RITA (the RITA versus RA arm of the RAPCO trial), 394 patients <70 years of age (or <60 years of age if they had diabetes mellitus) were randomized to receive RA or free RITA graft on the second most important coronary target. In RAPCO-SV (the SV versus RA arm of the RAPCO trial), 225 patients ≥70 years of age (or ≥60 years of age if they had diabetes mellitus) were randomized to receive RA or SV graft. The primary outcome was 10-year graft failure. Long-term mortality was a nonpowered coprimary end point. The main analysis was by intention to treat. Results: In the RA versus RITA comparison, the estimated 10-year patency was 89% for RA versus 80% for free RITA (hazard ratio for graft failure, 0.45 [95% CI, 0.23–0.88]). Ten-year patient survival estimate was 90.9% in the RA arm versus 83.7% in the RITA arm (hazard ratio for mortality, 0.53 [95% CI, 0.30–0.95]). In the RA versus SV comparison, the estimated 10-year patency was 85% for the RA versus 71% for the SV (hazard ratio for graft failure, 0.40 [95% CI, 0.15–1.00]), and 10-year patient survival estimate was 72.6% for the RA group versus 65.2% for the SV group (hazard ratio for mortality, 0.76 [95% CI, 0.47–1.22]). Conclusions: The 10-year patency rate of the RA is significantly higher than that of the free RITA and better than that of the SV. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00475488.


2020 ◽  
Author(s):  
Yasuhiko Kawaguchi ◽  
Hideki Kitamura ◽  
Kazuya Konakano ◽  
Mototsugu Tamaki ◽  
Yasuhide Okawa

Sign in / Sign up

Export Citation Format

Share Document